Lv1
80 积分 2021-03-17 加入
Non‐Bismuth Quadruple Concomitant Treatment for Helicobacter pylori Eradication: A Systematic Review and Meta‐Analysis
1个月前
已完结
Sa1378 HELICOBACTER PYLORI ERADICATION TREATMENT REGIMEN SELECTION FOR PATIENTS WITH DECREASED RENAL FUNCTION: A SYSTEMATIC REVIEW
1个月前
已关闭
Eradication Therapy for Helicobacter pylori Infection in Patients Receiving Hemodialysis: Review
1个月前
已完结
#3318 PHASE II DOSE-SELECTION, RANDOMISED DOUBLE-BLIND TRIAL OF THE ASI, BI 690517, ALONE AND IN COMBINATION WITH EMPA IN PEOPLE WITH CKD
2个月前
已完结
#1418 Phase II dose-selection, randomised, controlled trial of ASi BI 690517 with and without EMPA in CKD: subgroup analysis by T2D status
2个月前
已完结
#3315 Vicadrostat with and without empagliflozin reduces albuminuria across KDIGO risk class in chronic kidney disease
2个月前
已完结
Methods Article for a Study Protocol: Study Design and Baseline Characteristics for Aldosterone Synthase Inhibition in Chronic Kidney Disease
2个月前
已完结
Subgroup results from KARDIA-2: impact of demographic and baseline disease characteristics on zilebesiran response in patients with hypertension uncontrolled by a standard oral antihypertensive
2个月前
已完结
The impact of tolvaptan on the incidence of contrast-induced acute kidney injury and long-term prognosis in high-risk patients after coronary intervention
2个月前
已完结
Within-host population dynamics of extensively drug-resistant Mycobacterium tuberculosis revealed by an over 3-year longitudinal study
3个月前
已完结
皖公网安备34019202002308
